Formulate and Evaluate, Fast Dissolving thin Film of Metoprolol Succinate

نویسندگان

چکیده

Objective: Metoprolol succinate, which is used to treat cardiovascular disorders, a strong beta-1 adrenoreceptor blocker with cardio-selective effect but heavily metabolised in the liver during first pass. Our goal minimise hypertension by creating film of metoprolol succinate that dissolves quickly.
 Methods: films dissolve mouth were made utilising solvent casting technique. HPMC E5 was as film-forming agent, PEG400 plasticizer, and honey included film-modifying agent final formulation. E15 (X1) (X2) concentrations independent variables, whereas disintegration time (DT), tensile strength (TS), % cumulative drug release (CDR) dependent variables 32-full factorial design. Thickness, folding endurance, strength, time, among criteria assess manufactured films. Results showed both positively impacted DT TS while negatively impacting CDR.
 Results: The optimum formulation determined be one 58.0 ±1.01 seconds, an vitro 105.32± 1.55, 73.55 ± 1.37 g/cm2.
 Conclusion: Thus, employing method, fast-dissolving thin created effective taste masking prompt release.
 Keywords: Fast dissolving oral film, E5, Honey, Solvent

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Formulation Development and Evaluation of Fast Dissolving Film of Telmisartan

Hypertension is a major cause of concern not just in the elderly but also in the youngsters. An effort was made to formulate a fast dissolving film containing telmisartan which is used in the treatment of hypertension with a view to improve the onset of action, therapeutic efficacy, patient compliance and convenience. The major challenge in formulation of oral films of telmisatran is that it sh...

متن کامل

Simultaneous Estimation of Metoprolol Succinate and Olmesartan

A simple, precise, specific and accurate reverse phase HPLC method has been developed for the simultaneous determination of Metoprolol succinate (METO) and Olmesartan medoxomil (OLME) in tablet dosage form. The chromatographic separation was achieved on inertsil ODS 3V (250 mm×4.6 mm, 5 μm) column using PDA detector. The mobile phase consisting of Buffer (2 ml O-phosphoric acid in 2000 ml milli...

متن کامل

Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate

The aim of the present work was to prepare and evaluate sublingual fast dissolving films containing metoprolol tartrate-loaded niosomes. Niosomes were utilized to allow for prolonged release of the drug, whereas the films were used to increase the drug's bioavailability via the sublingual route. Niosomes were prepared using span 60 and cholesterol at different drug to surfactant ratios. The nio...

متن کامل

Metoprolol succinate therapy associated with erythema multiforme.

Metoprolol succinate is a widely used medication for the management of hypertension, heart failure, and angina. We report the case of a 36-year-old woman who developed erythema multiforme after administration of a low dose of this drug. She also presented with pruritic burning pain throughout her body accompanied by chills. While erythema multiforme has been reported with carvedilol, this is th...

متن کامل

Metoprolol succinate extended release/hydrochlorothiazide combination tablets

Lowering elevated blood pressure (BP) with drug therapy reduces the risk for catastrophic fatal and nonfatal cardiovascular events such as stroke and myocardial infarction. Given the heterogeneity of hypertension as a disease, the marked variability in an individual patient's BP response, and low response rates with monotherapy, expert groups such as the Joint National Committee (JNC) emphasize...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Biomedical and Pharmaceutical Research

سال: 2023

ISSN: ['2279-0594', '2589-8752']

DOI: https://doi.org/10.32553/jbpr.v12i3.1000